Does EMTRICITABINE\TENOFOVIR DISOPROXIL Cause Neoplasm progression? 39 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Neoplasm progression have been filed in association with EMTRICITABINE\TENOFOVIR DISOPROXIL. This represents 0.1% of all adverse event reports for EMTRICITABINE\TENOFOVIR DISOPROXIL.
39
Reports of Neoplasm progression with EMTRICITABINE\TENOFOVIR DISOPROXIL
0.1%
of all EMTRICITABINE\TENOFOVIR DISOPROXIL reports
0
Deaths
6
Hospitalizations
How Dangerous Is Neoplasm progression From EMTRICITABINE\TENOFOVIR DISOPROXIL?
Of the 39 reports, 6 (15.4%) required hospitalization.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMTRICITABINE\TENOFOVIR DISOPROXIL. However, 39 reports have been filed with the FAERS database.
What Other Side Effects Does EMTRICITABINE\TENOFOVIR DISOPROXIL Cause?
Bone density decreased (16,315)
Chronic kidney disease (10,248)
Bone loss (8,967)
Osteonecrosis (8,935)
Renal failure (8,618)
Multiple fractures (8,088)
Renal injury (8,000)
Tooth loss (7,981)
Osteoporosis (7,436)
Skeletal injury (7,161)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which EMTRICITABINE\TENOFOVIR DISOPROXIL Alternatives Have Lower Neoplasm progression Risk?
EMTRICITABINE\TENOFOVIR DISOPROXIL vs ENALAPRIL
EMTRICITABINE\TENOFOVIR DISOPROXIL vs ENALAPRIL\HYDROCHLOROTHIAZIDE
EMTRICITABINE\TENOFOVIR DISOPROXIL vs ENALAPRIL\LERCANIDIPINE
EMTRICITABINE\TENOFOVIR DISOPROXIL vs ENASIDENIB
EMTRICITABINE\TENOFOVIR DISOPROXIL vs ENBREL